Drug Trial Radar · NCT06962839
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
300
Planned (sponsor's estimate)
Start
Jun 5, 2025
Primary completion
Mar 1, 2028
Study completion Mar 29, 2028
Sponsor
- Lead sponsor
- Boehringer IngelheimBoehringer Ingelheim
- Sponsor type
- Industry
- First posted
- May 8, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is open to adults 18 and older with an eye condition called diabetic macular edema. People are required to have a specific type of diabetic macular edema called centre-involved diabetic macular edema (CI-DME) to take part. The purpose of this study is to find out whether a medicine called BI 1815368 improves sight in people with CI-DME and to find the most suitable dose. This study has 2 parts. In the first part, participants are put into 2 groups of equal size randomly, which means by chance. One group takes BI 1815368 tablets and the other group takes placebo tablets. Placebo tablets look like BI 1815368 tablets but do not contain any medicine. In the second part, participants are put into 4 groups of equal size randomly. 3 groups take different daily doses of the study medicine, BI 1815368, while 1 group takes placebo. All participants take tablets twice a day for about 11 months. Participants are in the study for about 1 year. During this time, they visit the study site at least 16 times. Participants taking metformin have 3 additional study visits. At visits, doctors check the participant's vision and collect information on any health problems. They take detailed pictures of the eye. The changes over time are compared between the groups to see if the treatment works.
Conditions
- Macular Edema
Interventions
BI 1815368Drug
BI 1815368
PlaceboDrug
Placebo matching BI 1815368
Primary outcomes
What the sponsor says the trial is designed to measure.
- Occurrence (yes/no) of a gain of ≥10 Early Treatment Diabetic Retinopathy Study (ETDRS) letters compared with baseline in the study eye at Week 48Time frame: at baseline, at week 48
Locations
98 sites in 9 countries. Site status is shown where the registry gives one.
Arizona Retina & Vitreous Research, Central Phoenix
Phoenix, Arizona · Recruiting
Win Retina
Arcadia, California · Recruiting
Retina Associates of Southern California
Huntington Beach, California · Recruiting
Retinal Consultants Medical Group, Inc
Modesto, California · Recruiting
Eye Research Foundation
Newport Beach, California · Recruiting
Doheny Eye Center UCLA Arcadia
Pasadena, California · Recruiting
Retina Consultants of San Diego
Poway, California · Recruiting
West Coast Retina Medical Group, Inc.
San Francisco, California · Recruiting
Colorado Retina Associates
Lakewood, Colorado · Recruiting
Connecticut Eye Consultants, PC
Danbury, Connecticut · Not yet recruiting
Retina Group of Florida - Fort Lauderdale Retina Center
Fort Lauderdale, Florida · Not yet recruiting
Florida Retina Institute, Jacksonville Southside
Jacksonville, Florida · Not yet recruiting
Advanced Research Institute
Pompano Beach, Florida · Recruiting
East Florida Eye Institute
Stuart, Florida · Not yet recruiting
Center for Retina and Macular Disease
Winter Haven, Florida · Recruiting
Southeast Retina Center, PC
Augusta, Georgia · Not yet recruiting
Associated Vitreoretinal and Uveitis Consultants
Carmel, Indiana · Recruiting
University of Kansas Medical Center
Kansas City, Kansas · Recruiting
Cumberland Valley Retina Consultants
Hagerstown, Maryland · Recruiting
Deep Blue Retina Clinical Research PLLC
Southaven, Mississippi · Not yet recruiting
Sierra Eye Associates
Reno, Nevada · Recruiting
North Carolina Retina Associates
Wake Forest, North Carolina · Recruiting
Cleveland Clinic
Cleveland, Ohio · Recruiting
Verum Research, LLC
Eugene, Oregon · Recruiting
Retina Consultants of Carolina, P.A.
Greenville, South Carolina · Recruiting
Tennessee Retina
Nashville, Tennessee · Recruiting
Austin Research Center for Retina, PLLC
Austin, Texas · Recruiting
Austin Retina Associates
Austin, Texas · Recruiting
Austin Clinical Research, LLC
Austin, Texas · Recruiting
Retina Consultants of Texas - Beaumont
Beaumont, Texas · Not yet recruiting
Texas Retina Associates
Dallas, Texas · Recruiting
Star Retina
Fort Worth, Texas · Not yet recruiting
Medical Center Ophthalmology Associates
San Antonio, Texas · Not yet recruiting
Retinal Consultants of San Antonio
San Antonio, Texas · Not yet recruiting
Retina Center Of Texas
Southlake, Texas · Recruiting
Retina Consultants of Texas
The Woodlands, Texas · Recruiting
Piedmont Eye Center
Lynchburg, Virginia · Recruiting
Retina Consultants, PLLC
Charleston, West Virginia · Not yet recruiting
West China Hospital, Sichuan University
Chengdu, China · Recruiting
Shanghai General Hospital
Shanghai, China · Recruiting
Showing 40 of 98 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.